http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2000080045-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_129e393582e6bdf4029baf2206522f45 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-21 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 |
filingDate | 1999-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5bc1aa39e2073ba56a5ced1c4793e89a |
publicationDate | 2000-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-2000080045-A |
titleOfInvention | Heart disease treatment |
abstract | (57) Abstract: A therapeutic agent for heart disease in which myocardial tissue is infected with human hepatitis C virus, comprising an antiviral agent as an active ingredient. Effect The therapeutic agent for heart disease of the present invention is useful as a therapeutic agent for viral myocarditis and heart disease related thereto. |
priorityDate | 1995-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 113.